Publications
Articles
A first-in-human, open-label Phase 1b and a randomised, double-blind Phase 2a clinical trial in recent-onset type 1 diabetes with AG019 as monotherapy and in combination with teplizumab
(2024). Diabetologia, 67 (1), 27-41. http://dx.doi.org/10.1007/s00125-023-06014-2, PMID: 37782353, PMCID: PMC10709251
Mathieu C, Wiedeman A, Cerosaletti K, Long SA, Serti E, Cooney L, Vermeiren J, Caluwaerts S, Van Huynegem K, Van Huynegem K, Steidler L, Blomme S, Rottiers P, Nepom GT, Herold KC, AG019-T!D-101 Trial Investigators
[PubMed]
[Citation View]
Mathieu C, Wiedeman A, Cerosaletti K, Long SA, Serti E, Cooney L, Vermeiren J, Caluwaerts S, Van Huynegem K, Van Huynegem K, Steidler L, Blomme S, Rottiers P, Nepom GT, Herold KC, AG019-T!D-101 Trial Investigators (2024). A first-in-human, open-label Phase 1b and a randomised, double-blind Phase 2a clinical trial in recent-onset type 1 diabetes with AG019 as monotherapy and in combination with teplizumab. Diabetologia, 67 (1), 27-41.
Immunosuppression withdrawal in living-donor renal transplant recipients following induction with antithymocyte globulin and rituximab: Results of a prospective clinical trial.
(2024). Am J Transplant., Epub ahead of print. http://dx.doi.org/10.1016/j.ajt.2024.03.007, PMID: 38467375
Markmann JF, Burrell BE, Bromberg JS, Hartono C, Kaufman DB, Possselt AM, Naji A, Bridges ND, Breeden C, Kanaparthi S, Pardo J, Kopetskie H, Mason K, Lim N, Chandran S.
[Reprint] [PubMed]
[Citation View]
Markmann JF, Burrell BE, Bromberg JS, Hartono C, Kaufman DB, Possselt AM, Naji A, Bridges ND, Breeden C, Kanaparthi S, Pardo J, Kopetskie H, Mason K, Lim N, Chandran S. (2024). Immunosuppression withdrawal in living-donor renal transplant recipients following induction with antithymocyte globulin and rituximab: Results of a prospective clinical trial.. Am J Transplant., Epub ahead of print.
Impact on in-depth immunophenotyping of delay to peripheral blood processing
(2024). Clin Exp Immunol, Epub. http://dx.doi.org/10.1093/cei/uxae041, PMID: 38693758
Higdon LE, Scheiding S, Kus AM, Lim N, Long SA, Anderson MS, Wiedeman AE.
[PubMed]
[Citation View]
Higdon LE, Scheiding S, Kus AM, Lim N, Long SA, Anderson MS, Wiedeman AE. (2024). Impact on in-depth immunophenotyping of delay to peripheral blood processing. Clin Exp Immunol, Epub.
Follow-up to Adolescence after Early Peanut Introduction for Allergy Prevention
(2024). NEJM Evidence, Epub ahead of print. http://dx.doi.org/10.1056/EVIDoa2300311, PMID: 38804779
Du Toit G, Radulovic S, Feeney M, Fisher HR, Byron M, Dunaway L, Calatroni A, Johnson M, Foong RX, Marques-Mejias A, Bartha I, Basting M, Brough HA, Baloh C, Laidlaw TM, Bahnson HT, Roberts G, Plaut M, Wheatley LM, Lack G; Immune Tolerance Network LEAP-Trio Trial Team
[PubMed]
[Citation View]
Du Toit G, Radulovic S, Feeney M, Fisher HR, Byron M, Dunaway L, Calatroni A, Johnson M, Foong RX, Marques-Mejias A, Bartha I, Basting M, Brough HA, Baloh C, Laidlaw TM, Bahnson HT, Roberts G, Plaut M, Wheatley LM, Lack G; Immune Tolerance Network LEAP-Trio Trial Team (2024). Follow-up to Adolescence after Early Peanut Introduction for Allergy Prevention. NEJM Evidence, Epub ahead of print.
Interconnected lineage trajectories link conventional and natural killer (NK)-like exhaustedCD8+ T cells beneficial in type 1 diabetes
(2024). Communications biology, 7 (1), 773. http://dx.doi.org/10.1038/s42003-024-06456-3, PMID: 38937521, PMCID: PMC11211332
Witkop, EM. Diggins, K. Weideman, A. Serti, E. Nepom, G. Gersuk, VH. Fuchs, B. Long, SA. Linsley, PS.
[Reprint] [PubMed]
[Citation View]
Witkop, EM. Diggins, K. Weideman, A. Serti, E. Nepom, G. Gersuk, VH. Fuchs, B. Long, SA. Linsley, PS. (2024). Interconnected lineage trajectories link conventional and natural killer (NK)-like exhaustedCD8+ T cells beneficial in type 1 diabetes. Communications biology, 7 (1), 773.
Defining the window of opportunity and the target populations to prevent peanut allergy
(2023). J Allergy Clin Immunol., 151 (5), 1329-1336. http://dx.doi.org/10.1016/j.jaci.2022.09.042, PMID: 36521802, PMCID: PMC10689252
Roberts, G. Bahnson. HT. Du Toit, G. O’Rourk, C. Sever, M, Brittain, E. Plaut, M. Lack, G.
[Reprint] [PubMed]
[Citation View]
Roberts, G. Bahnson. HT. Du Toit, G. O’Rourk, C. Sever, M, Brittain, E. Plaut, M. Lack, G. (2023). Defining the window of opportunity and the target populations to prevent peanut allergy. J Allergy Clin Immunol., 151 (5), 1329-1336.
In children with eczema, expansion of epitope-specific IgE is associated with peanut allergy at 5 years of age.
(2023). Allergy, 78 (2), 586-589.. http://dx.doi.org/10.1111/all.15572, PMID: 36321870
Suprun M, Bahnson HT, Du Toit G, Lack G, Suarez-Farinas M, Sampson HA.
[Reprint] [PubMed]
[Citation View]
Suprun M, Bahnson HT, Du Toit G, Lack G, Suarez-Farinas M, Sampson HA. (2023). In children with eczema, expansion of epitope-specific IgE is associated with peanut allergy at 5 years of age.. Allergy, 78 (2), 586-589..
Autoreactive Plasmablasts After B Cell Depletion With Rituximab and Relapses in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
(2023). Arthritis Rheumatol, 75 (5), 736-747. http://dx.doi.org/10.1002/art.42388, PMID: 36281741, PMCID: PMC10280646
Berti A, Hillion S, Konig MF, Casal Moura M, Hummel AM, Carmona E, Peikert T, Fervenza FC, Kallenberg CGM, Langford CA, Merkel PA, Monach PA, Seo P, Spiera RF, Brunetta P, St Clair EW, Harris KM, Stone JH, Grandi G, Pers JO, Specks U, Cornec D.
[Reprint] [PubMed]
[Citation View]
Berti A, Hillion S, Konig MF, Casal Moura M, Hummel AM, Carmona E, Peikert T, Fervenza FC, Kallenberg CGM, Langford CA, Merkel PA, Monach PA, Seo P, Spiera RF, Brunetta P, St Clair EW, Harris KM, Stone JH, Grandi G, Pers JO, Specks U, Cornec D. (2023). Autoreactive Plasmablasts After B Cell Depletion With Rituximab and Relapses in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Rheumatol, 75 (5), 736-747.
Omics-Oriented Research illustrated with the LEAP Study and the OASIS Bioinformatics Tool.
(2023). The Journal of Allergy and Clinical Immunology, 151 (2), 416-419. http://dx.doi.org/10.1016/j.jaci.2022.12.003, PMID: 36521801
Baloh CH, Kanchan K, Shankar G, Nepom GT, Mathias RA, Perry JA.
[Reprint] [PubMed]
[Citation View]
Baloh CH, Kanchan K, Shankar G, Nepom GT, Mathias RA, Perry JA. (2023). Omics-Oriented Research illustrated with the LEAP Study and the OASIS Bioinformatics Tool.. The Journal of Allergy and Clinical Immunology, 151 (2), 416-419.
Activation of a Latent Epitope Causing Differential Binding of Anti-Neutrophil Cytoplasmic Antibodies to Proteinase 3
(2023). Arthritis Rheumatol, 75 (5), 748-759. http://dx.doi.org/10.1002/art.42418, PMID: 36515151, PMCID: 10191989
Moura MC, Thompson GE, Nelson DR, Fussner LA, Hummel AM, Jenne DE, Emerling D, Fervenza FC, Kallenberg CGM, Langford CA, McCune WJ, Merkel PA, Monach PA, Seo P, Spiera RF, St Clair EW, Ytterberg SR, Stone JH, Robinson WH, Specks U
[Reprint] [PubMed]
[Citation View]
Moura MC, Thompson GE, Nelson DR, Fussner LA, Hummel AM, Jenne DE, Emerling D, Fervenza FC, Kallenberg CGM, Langford CA, McCune WJ, Merkel PA, Monach PA, Seo P, Spiera RF, St Clair EW, Ytterberg SR, Stone JH, Robinson WH, Specks U (2023). Activation of a Latent Epitope Causing Differential Binding of Anti-Neutrophil Cytoplasmic Antibodies to Proteinase 3. Arthritis Rheumatol, 75 (5), 748-759.
Risk factors for serious infections in ANCA-associated vasculitis
(2023). Annals of the Rheumatic Diseases, 82 (5), 681-687. http://dx.doi.org/0.1136/ard-2022-223401, PMID: 36702528, PMCID: 10176387
Odler B, Riedl R, Gauckler P, Shin JI, Leierer J, Merkel PA, St Clair W, Fervenza F, Geetha D, Monach P, Jayne D, Smith RM, Rosenkranz A, Specks U, Stone JH, Kronbichler A; RAVE−ITN Research Group.
[Reprint] [PubMed]
[Citation View]
Odler B, Riedl R, Gauckler P, Shin JI, Leierer J, Merkel PA, St Clair W, Fervenza F, Geetha D, Monach P, Jayne D, Smith RM, Rosenkranz A, Specks U, Stone JH, Kronbichler A; RAVE−ITN Research Group. (2023). Risk factors for serious infections in ANCA-associated vasculitis. Annals of the Rheumatic Diseases, 82 (5), 681-687.
Meeting Report: The Fifth International Samuel Strober Workshop on Clinical Immune Tolerance
(2023). Transplantation, 107 (3), 564-569. http://dx.doi.org/10.1097/TP.0000000000004473, PMID: 36808845
Sykes M, Chandran S, Kawai T, Levitsky J, Mapara M, Mathew J, Thomson A, Yamada K.
[Reprint] [PubMed]
[Citation View]
Sykes M, Chandran S, Kawai T, Levitsky J, Mapara M, Mathew J, Thomson A, Yamada K. (2023). Meeting Report: The Fifth International Samuel Strober Workshop on Clinical Immune Tolerance. Transplantation, 107 (3), 564-569.
Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial.
(2023). Diabetes Care., 46 (5), 1005-1013. http://dx.doi.org/10.2337/dc22-2200, PMID: 36920087, PMCID: 10154649
Russell WE, Bundy BN, Anderson MS, Cooney LA, Gitelman SE, Goland RS, Gottlieb PA, Greenbaum CJ, Haller MJ, Krischer JP, Libman IM, Linsley PS, Long SA, Lord SM, Moore DJ, Moore WV, Moran AM, Muir AB, Raskin P, Skyler JS, Wentworth JM, Wherrett DK, Wilson DM, Ziegler AG, Herold KC; Type 1 Diabetes TrialNet Study Group.
[PubMed]
[Citation View]
Russell WE, Bundy BN, Anderson MS, Cooney LA, Gitelman SE, Goland RS, Gottlieb PA, Greenbaum CJ, Haller MJ, Krischer JP, Libman IM, Linsley PS, Long SA, Lord SM, Moore DJ, Moore WV, Moran AM, Muir AB, Raskin P, Skyler JS, Wentworth JM, Wherrett DK, Wilson DM, Ziegler AG, Herold KC; Type 1 Diabetes TrialNet Study Group. (2023). Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial. . Diabetes Care., 46 (5), 1005-1013.
Developing a Prediction Model for Determination of Peanut Allergy Status in the LEAP Studies
(2023). J Allergy Clin Immunol Pract, 11 (7), 2217-2227.e9. http://dx.doi.org/10.1016/j.jaip.2023.04.032, PMID: 37146884
Sever ML, Calatroni A, Roberts G, Du Toit G, Bahnson HT, Radulovic S, Larson D, Byron M, Santos AF, Huffaker MF, Wheatley LM, Lack G.
[PubMed]
[Citation View]
Sever ML, Calatroni A, Roberts G, Du Toit G, Bahnson HT, Radulovic S, Larson D, Byron M, Santos AF, Huffaker MF, Wheatley LM, Lack G. (2023). Developing a Prediction Model for Determination of Peanut Allergy Status in the LEAP Studies. J Allergy Clin Immunol Pract, 11 (7), 2217-2227.e9.
Early introduction of peanut reduces peanut allergy across risk groups in pooled and causal inference analyses
(2023). Allergy, 78 (5), 1307-1318. http://dx.doi.org/10.1111/all.15597, PMID: 36435990, PMCID: 10202125
Logan K, Bahnson HT, Ylescupidez A, Beyer K, Bellach J, Campbell DE, Craven J, Du Toit G, Clare Mills EN, Perkin MR, Roberts G, van Ree R, Lack G
[PubMed]
[Citation View]
Logan K, Bahnson HT, Ylescupidez A, Beyer K, Bellach J, Campbell DE, Craven J, Du Toit G, Clare Mills EN, Perkin MR, Roberts G, van Ree R, Lack G (2023). Early introduction of peanut reduces peanut allergy across risk groups in pooled and causal inference analyses. Allergy, 78 (5), 1307-1318.
Understanding heterogeneity of human bone marrow plasma cell maturation and survival pathways by single-cell analyses.
(2023). Cell Reports, 42 (7), 112682. http://dx.doi.org/10.1016/j.celrep.2023.112682, PMID: 37355988, PMCID: PMC10391632
Duan, M., Nguyen, D. C., Joyner, C. J., Saney, C. L., Tipton, C. M., Andrews, J., Lonial, S., Kim, C., Hentenaar, I., Kosters, A., Ghosn, E., Jackson, Knechtle, Maruthamuthu, Chandran, Martin, T., Rajalingam, R., Vincenti, F., Breeden, Sanz, Gibson, G., Lee, F. E.
[PubMed]
[Citation View]
Duan, M., Nguyen, D. C., Joyner, C. J., Saney, C. L., Tipton, C. M., Andrews, J., Lonial, S., Kim, C., Hentenaar, I., Kosters, A., Ghosn, E., Jackson, Knechtle, Maruthamuthu, Chandran, Martin, T., Rajalingam, R., Vincenti, F., Breeden, Sanz, Gibson, G., Lee, F. E. (2023). Understanding heterogeneity of human bone marrow plasma cell maturation and survival pathways by single-cell analyses.. Cell Reports, 42 (7), 112682.
Islet-autoreactive CD4+ T cells are linked with response to alefacept in type 1 diabetes
(2023). JCI Insight, 8 (21), e167881. http://dx.doi.org/10.1172/jci.insight.167881, PMID: 37751304, PMCID: 10721267
Balmas E, Chen J, Hu AK, DeBerg HA, Rosasco MG, Gersuk VH, Serti E, Speake C, Greenbaum CJ, Nepom GT, Linsley P. Cerosaletti
[Reprint] [PubMed]
[Citation View]
Balmas E, Chen J, Hu AK, DeBerg HA, Rosasco MG, Gersuk VH, Serti E, Speake C, Greenbaum CJ, Nepom GT, Linsley P. Cerosaletti (2023). Islet-autoreactive CD4+ T cells are linked with response to alefacept in type 1 diabetes. JCI Insight, 8 (21), e167881.
Latent EBV impairs immune cell signaling and enhances the efficacy of anti-CD3 mAb in Type 1 Diabetes
(2023). medRxiv, Epub ahead of print. http://dx.doi.org/10.1101/2023.07.11.23292344, PMID: 37502867, PMCID: PMC10370230
Delgado AL, Preston-Hurlburt P, Lim N, Sumida TS, Long SA, McNamara J, Serti E, Higdon L, Herold KC
[PubMed]
[Citation View]
Delgado AL, Preston-Hurlburt P, Lim N, Sumida TS, Long SA, McNamara J, Serti E, Higdon L, Herold KC (2023). Latent EBV impairs immune cell signaling and enhances the efficacy of anti-CD3 mAb in Type 1 Diabetes. medRxiv, Epub ahead of print.
Th2 cell clonal expansion at diagnosis in human type 1 diabetes
(2023). Clinical Immunology, 257, 109829. http://dx.doi.org/10.1016/j.clim.2023.109829, PMID: 37907122
Narsale A, Almanza F, Tran T, Lam B, Seo D, Vu A, Long SA, Cooney L, Serti E, Davies JD
[Reprint] [PubMed]
[Citation View]
Narsale A, Almanza F, Tran T, Lam B, Seo D, Vu A, Long SA, Cooney L, Serti E, Davies JD (2023). Th2 cell clonal expansion at diagnosis in human type 1 diabetes. Clinical Immunology, 257, 109829.
Nasal and blood transcriptomic pathways underpinning the clinical response to grass pollen immunotherapy
(2023). J Allergy Clin Immunol, 152 (5), 1247-1260. http://dx.doi.org/10.1016/j.jaci.2023.06.025, PMID: 37460024, PMCID: PMC10788383
Altman MC, Segnitz RM, Larson D, Jayavelu ND, Smith MT, Patel S, Scadding GW, Qin T, Sanda S, Steveling E, Eifan AO, Penagos M, Jacobson MR, Parkin RV, Shamji MH, Togias A, Durham SR
[PubMed]
[Citation View]
Altman MC, Segnitz RM, Larson D, Jayavelu ND, Smith MT, Patel S, Scadding GW, Qin T, Sanda S, Steveling E, Eifan AO, Penagos M, Jacobson MR, Parkin RV, Shamji MH, Togias A, Durham SR (2023). Nasal and blood transcriptomic pathways underpinning the clinical response to grass pollen immunotherapy. J Allergy Clin Immunol, 152 (5), 1247-1260.
Distinct trajectories distinguish antigen-specific T cells in peanut-allergic individuals undergoing oral immunotherapy
(2023). J Allergy Clin Immunol, 152 (1), 155-166.e9. http://dx.doi.org/10.1016/j.jaci.2023.03.020, PMID: 37003475, PMCID: 10330178
Calise J, DeBerg HA, Garabatos N, Khosa S, Bajzik V, Botero Calderon L, Aldridge K, Rosasco M, Ferslew BC, Zhu T, Smulders R, Wheatley LM, Laidlaw TM, Qin T, Chichili GR, Adelman DC, Farrington M, Robinson D, Jeong D, Jones SM, Sanda S, Larson D, Kwok WW, Baloh C, Nepom GT, Wambre E, IMPACT investigators
[PubMed]
[Citation View]
Calise J, DeBerg HA, Garabatos N, Khosa S, Bajzik V, Botero Calderon L, Aldridge K, Rosasco M, Ferslew BC, Zhu T, Smulders R, Wheatley LM, Laidlaw TM, Qin T, Chichili GR, Adelman DC, Farrington M, Robinson D, Jeong D, Jones SM, Sanda S, Larson D, Kwok WW, Baloh C, Nepom GT, Wambre E, IMPACT investigators (2023). Distinct trajectories distinguish antigen-specific T cells in peanut-allergic individuals undergoing oral immunotherapy. J Allergy Clin Immunol, 152 (1), 155-166.e9.
Self-reactive germline-like TCR alpha chains shared between blood and pancreas
(2023). Res Sq, NLM Preprint. http://dx.doi.org/10.21203/rs.3.rs-3446917/v1, PMID: 37886513, PMCID: 10602137
Linsley P, Nakayama M, Balmas E, Chen J, Pour F, Bansal S, Serti E, Speake C, Pugliese A, Cerosaletti K
[PubMed]
[Citation View]
Linsley P, Nakayama M, Balmas E, Chen J, Pour F, Bansal S, Serti E, Speake C, Pugliese A, Cerosaletti K (2023). Self-reactive germline-like TCR alpha chains shared between blood and pancreas. Res Sq, NLM Preprint.
Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study
(2022). Lancet, 399 (10322), 359-371. http://dx.doi.org/10.1016/S0140-6736(21)02390-4, PMID: 35065784, PMCID: PMC9119642
Jones SM, Nadeau KC, Nowak-Węgrzyn A, Wood RA, Sampson HA, Scurlock AM, Chinthrajah RS, Wang J, Pesek RD, Sindher SB, Kulis M, Spain K, Babineau DC, Chin H, Laurienzo-Panza J, Yan R, Qin T, Whitehouse D, Sever ML, Sanda S, Plaut M, Wheatley LM, Burks AW, Immune Tolerance Network
[Reprint] [PubMed]
[Citation View]
Jones SM, Nadeau KC, Nowak-Węgrzyn A, Wood RA, Sampson HA, Scurlock AM, Chinthrajah RS, Wang J, Pesek RD, Sindher SB, Kulis M, Spain K, Babineau DC, Chin H, Laurienzo-Panza J, Yan R, Qin T, Whitehouse D, Sever ML, Sanda S, Plaut M, Wheatley LM, Burks AW, Immune Tolerance Network (2022). Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study. Lancet, 399 (10322), 359-371.
HLA alleles and sustained peanut consumption promote IgG4 responses in subjects protected from peanut allergy
(2022). J Clin Invest, 132 (1). http://dx.doi.org/10.1172/JCI152070, PMID: 34981778, PMCID: PMC8718139
Kanchan K, Grinek S, Bahnson HT, Ruczinski I, Shankar G, Larson D, Du Toit G, Barnes KC, Sampson HA, Suarez-Farinas M, Lack G, Nepom GT, Cerosaletti K, Mathias RA
[Reprint] [PubMed]
[Citation View]
Kanchan K, Grinek S, Bahnson HT, Ruczinski I, Shankar G, Larson D, Du Toit G, Barnes KC, Sampson HA, Suarez-Farinas M, Lack G, Nepom GT, Cerosaletti K, Mathias RA (2022). HLA alleles and sustained peanut consumption promote IgG4 responses in subjects protected from peanut allergy. J Clin Invest, 132 (1).
Oral desensitization therapy for peanut allergy induces dynamic changes in peanut-specific immune responses
(2022). Allergy, 77 (8), 2534-2548. http://dx.doi.org/doi.org/10.1111/all.15276, PMID: 35266148, PMCID: 9356972
Bajzik V, DeBerg HA, Garabatos N, Rust BJ, Obrien KK, Nguyen QA, O'Rourke C, Smith A, Walker AH, Quinn C, Gersuk VH, Farrington M, Jeong D, Vickery BP, Adelman DC, Wambre E
[Reprint] [PubMed]
[Citation View]
Bajzik V, DeBerg HA, Garabatos N, Rust BJ, Obrien KK, Nguyen QA, O'Rourke C, Smith A, Walker AH, Quinn C, Gersuk VH, Farrington M, Jeong D, Vickery BP, Adelman DC, Wambre E (2022). Oral desensitization therapy for peanut allergy induces dynamic changes in peanut-specific immune responses. Allergy, 77 (8), 2534-2548.
A phase 1b open-label dose-finding study of ustekinumab in young adults with type 1 diabetes
(2022). Immunotherapy Advances, 2 (1), 1 -13. http://dx.doi.org/10.1093/immadv/ltab022, PMID: 35072168, PMCID: PMC8769169
Marwaha AK, Chow S, Pesenacker AM, Cook L, Sun A, Long SA, Yang JHM, Ward-Hartstonge KA, Williams E, Domingo-Vila C, Halani K, Harris KM, Tree TIM, Levings MK, Elliott T, Tan R, Dutz JP
[Reprint] [PubMed]
[Citation View]
Marwaha AK, Chow S, Pesenacker AM, Cook L, Sun A, Long SA, Yang JHM, Ward-Hartstonge KA, Williams E, Domingo-Vila C, Halani K, Harris KM, Tree TIM, Levings MK, Elliott T, Tan R, Dutz JP (2022). A phase 1b open-label dose-finding study of ustekinumab in young adults with type 1 diabetes. Immunotherapy Advances, 2 (1), 1 -13.
Early intervention and prevention of allergic diseases
(2022). Allergy, 77 (2), 416-441. http://dx.doi.org/10.1111/all.15006, PMID: 34255344
Brough HA, Lanser BJ, Sindher SB, Teng JMC, Leung DYM, Venter C, Chan SM, Santos AF, Bahnson HT, Guttman-Yassky E, Gupta RS, Lack G, Ciaccio CE, Sampath V, Nadeau KC, Nagler CR.
[Reprint] [PubMed]
[Citation View]
Brough HA, Lanser BJ, Sindher SB, Teng JMC, Leung DYM, Venter C, Chan SM, Santos AF, Bahnson HT, Guttman-Yassky E, Gupta RS, Lack G, Ciaccio CE, Sampath V, Nadeau KC, Nagler CR. (2022). Early intervention and prevention of allergic diseases. Allergy, 77 (2), 416-441.
Serum Biomarkers of Disease Activity in Longitudinal Assessment of Patients with ANCA-Associated Vasculitis
(2022). ACR Open Rheumatology, 4 (2), 168-176. http://dx.doi.org/doi.org/10.1002/acr2.11366, PMID: 34792864, PMCID: PMC8843765
Monach PA, Warner RL, Lew R, Tomasson G, Specks U, Stone JH, Fervenza FC, Hoffman GS, Kallenberg CGM, Langford CA, Seo P, St Clair EW, Spiera R, Johnson KJ, Merkel PA
[Reprint] [PubMed]
[Citation View]
Monach PA, Warner RL, Lew R, Tomasson G, Specks U, Stone JH, Fervenza FC, Hoffman GS, Kallenberg CGM, Langford CA, Seo P, St Clair EW, Spiera R, Johnson KJ, Merkel PA (2022). Serum Biomarkers of Disease Activity in Longitudinal Assessment of Patients with ANCA-Associated Vasculitis. ACR Open Rheumatology, 4 (2), 168-176.
Ex vivo generation of regulatory T cells from liver transplant recipients using costimulation blockade
(2022). Am J Transplant, 22 (2), 504-518. http://dx.doi.org/10.1111/ajt.16842, PMID: 34528383, PMCID: PMC9078620
Shimozawa K, Contreras-Ruiz L, Sousa S, Zhang R, Bhatia U, Crisalli KC, Brennan LL, Turka LA, Markmann JF, Guinan EC.
[Reprint] [PubMed]
[Citation View]
Shimozawa K, Contreras-Ruiz L, Sousa S, Zhang R, Bhatia U, Crisalli KC, Brennan LL, Turka LA, Markmann JF, Guinan EC. (2022). Ex vivo generation of regulatory T cells from liver transplant recipients using costimulation blockade. Am J Transplant, 22 (2), 504-518.
Next Generation Pathology Detection of T cell-Antigen Presenting Cell Immune Synapses in Human Liver Allografts
(2022). Hepatology, 77 (2), 355-366. http://dx.doi.org/10.1002/hep.32666, PMID: 35819312, PMCID: 9834436
Wood-Trageser MA, Lesniak D, Gambella A, Golnoski K, Feng S, Bucuvalas J, Sanchez-Fueyo A, Demetris AJ
[Reprint] [PubMed]
[Citation View]
Wood-Trageser MA, Lesniak D, Gambella A, Golnoski K, Feng S, Bucuvalas J, Sanchez-Fueyo A, Demetris AJ (2022). Next Generation Pathology Detection of T cell-Antigen Presenting Cell Immune Synapses in Human Liver Allografts. Hepatology, 77 (2), 355-366.
Effects of combination treatment with tezepelumab and allergen immunotherapy on nasal responses to allergen: a randomized controlled trial
(2022). Journal of Allergy and Clinical Immunology, 151 (1), 192-201. http://dx.doi.org/10.1016/j.jaci.2022.08.029, PMID: 36223848
Corren J, Larson D, Altman MC, Segnitz RM, Avila PC, Greenberger PA, Baroody F, Moss MH, Nelson H, Burbank AJ, Hernandez ML, Peden D, Saini S, Tilles S, Hussain I, Whitehouse D, Qin T, Villarreal M, Sever M, Wheatley LM, Nepom GT, Sanda S.
[Reprint] [PubMed]
[Citation View]
Corren J, Larson D, Altman MC, Segnitz RM, Avila PC, Greenberger PA, Baroody F, Moss MH, Nelson H, Burbank AJ, Hernandez ML, Peden D, Saini S, Tilles S, Hussain I, Whitehouse D, Qin T, Villarreal M, Sever M, Wheatley LM, Nepom GT, Sanda S. (2022). Effects of combination treatment with tezepelumab and allergen immunotherapy on nasal responses to allergen: a randomized controlled trial. Journal of Allergy and Clinical Immunology, 151 (1), 192-201.
Selective decrease of donor-reactive Tregs after liver transplantation limits Treg therapy for promoting allograft tolerance in humans
(2022). Sci Transl Med, 14, 669. http://dx.doi.org/10.1126/scitranslmed.abo2628, PMID: 36322627
Tang, Q. Leung, J. Peng, Y. Sanchez-Fueyo, A. Lozano, JJ. Lam, A. Lee, K. Greenland, JR. Hellerstein, M. Fitch, M. Li, KW. Esensten, JH. Putnam, AL. Lares, A. Nguyen, V. Liu, W. Bridges, ND. Odim, J. Demetris, AJ. Levitsky, J. Taner, T. Feng, S.
[Reprint] [PubMed]
[Citation View]
Tang, Q. Leung, J. Peng, Y. Sanchez-Fueyo, A. Lozano, JJ. Lam, A. Lee, K. Greenland, JR. Hellerstein, M. Fitch, M. Li, KW. Esensten, JH. Putnam, AL. Lares, A. Nguyen, V. Liu, W. Bridges, ND. Odim, J. Demetris, AJ. Levitsky, J. Taner, T. Feng, S. (2022). Selective decrease of donor-reactive Tregs after liver transplantation limits Treg therapy for promoting allograft tolerance in humans. Sci Transl Med, 14, 669.
IL-6-targeted therapies directed to cytokine or receptor blockade drive distinct alterations in T cell function
(2022). JCI Insight, 7 (22), e159436. http://dx.doi.org/10.1172/jci.insight.159436, PMID: 36282595, PMCID: PMC9746808
Speake C, Habib T, Lambert K, Hundhausen C, Lord S, Dufort MJ, Skinner SO, Hu A, Kinsman M, Jones BE, Maerz MD, Tatum M, Hocking AM, Nepom GT, Greenbaum CJ, Buckner JH
[Reprint] [PubMed]
[Citation View]
Speake C, Habib T, Lambert K, Hundhausen C, Lord S, Dufort MJ, Skinner SO, Hu A, Kinsman M, Jones BE, Maerz MD, Tatum M, Hocking AM, Nepom GT, Greenbaum CJ, Buckner JH (2022). IL-6-targeted therapies directed to cytokine or receptor blockade drive distinct alterations in T cell function. JCI Insight, 7 (22), e159436.
Graft Fibrosis Over 10 to 15 Years in Pediatric Liver Transplant Recipients: Multicenter Study of Paired, Longitudinal Surveillance Biopsies
(2022). Liver Transplantation, 28 (6), 1051-1062. http://dx.doi.org/10.1002/lt.26409, PMID: 35029022
Perito ER, Persyn E, Bucuvalas J, Martinez M, Mohammad S, Squires JE, Demetris AJ, Feng S.
[Reprint] [PubMed]
[Citation View]
Perito ER, Persyn E, Bucuvalas J, Martinez M, Mohammad S, Squires JE, Demetris AJ, Feng S. (2022). Graft Fibrosis Over 10 to 15 Years in Pediatric Liver Transplant Recipients: Multicenter Study of Paired, Longitudinal Surveillance Biopsies. Liver Transplantation, 28 (6), 1051-1062.
Standardizing the histological assessment of late posttransplantation biopsies from pediatric liver allograft recipients
(2022). Liver Transplantation, 28 (9), 1475-1489. http://dx.doi.org/10.1002/lt.26482, PMID: 35429359
Hübscher SG, Feng S, Gouw ASH, Haga H, Kang HJ, Kelly DA, Komuta M, Lesniak A, Popp BA, Verkade HJ, Yu E, Demetris AJ.
[Reprint] [PubMed]
[Citation View]
Hübscher SG, Feng S, Gouw ASH, Haga H, Kang HJ, Kelly DA, Komuta M, Lesniak A, Popp BA, Verkade HJ, Yu E, Demetris AJ. (2022). Standardizing the histological assessment of late posttransplantation biopsies from pediatric liver allograft recipients. Liver Transplantation, 28 (9), 1475-1489.
Peanut-Specific IgG4 and IgA in Saliva Are Modulated by Peanut Oral Immunotherapy
(2022). The Journal of Allergy and Clinical Immunology, 10 (12), 3270-3275. http://dx.doi.org/10.1016/j.jaip.2022.07.030, PMID: 35944894, PMCID: 9742136
Smeekens JM, Baloh C, Lim N, Larson D, Qin T, Wheatley L, Kim EH, Jones SM, Burks AW, Kulis MD.
[Reprint] [PubMed]
[Citation View]
Smeekens JM, Baloh C, Lim N, Larson D, Qin T, Wheatley L, Kim EH, Jones SM, Burks AW, Kulis MD. (2022). Peanut-Specific IgG4 and IgA in Saliva Are Modulated by Peanut Oral Immunotherapy. The Journal of Allergy and Clinical Immunology, 10 (12), 3270-3275.
Association of baseline soluble immune checkpoints with the risk of relapse in PR3-ANCA vasculitis following induction of remission
(2022). Ann Rheum Dis, 82 (2), 253-261. http://dx.doi.org/10.1136/ard-2022-222479, PMID: 35973802
Gamerith G, Mildner F, Merkel PA, Harris K, Cooney L, Lim N, Spiera R, Seo P, Langford CA, Hoffman GS, St Clair EW, Fervenza FC, Monach P, Ytterberg SR, Geetha D, Amann A, Wolf D, Specks U, Stone JH, Kronbichler A.
[Reprint] [PubMed]
[Citation View]
Gamerith G, Mildner F, Merkel PA, Harris K, Cooney L, Lim N, Spiera R, Seo P, Langford CA, Hoffman GS, St Clair EW, Fervenza FC, Monach P, Ytterberg SR, Geetha D, Amann A, Wolf D, Specks U, Stone JH, Kronbichler A. (2022). Association of baseline soluble immune checkpoints with the risk of relapse in PR3-ANCA vasculitis following induction of remission. Ann Rheum Dis, 82 (2), 253-261.
Stabilization of leukocytes from cerebrospinal fluid for central immunophenotypic evaluation in multicenter clinical trials
(2022). J Immunol Methods, 510, 113344. http://dx.doi.org/10.1016/j.jim.2022.113344, PMID: 36041516
Mexhitaj I, Lim N, Fernandez-Velasco JI, Zrzavy T, Harris KM, Muraro PA, Villar LM, Bar-Or A, Cooney LA.
[Reprint] [PubMed]
[Citation View]
Mexhitaj I, Lim N, Fernandez-Velasco JI, Zrzavy T, Harris KM, Muraro PA, Villar LM, Bar-Or A, Cooney LA. (2022). Stabilization of leukocytes from cerebrospinal fluid for central immunophenotypic evaluation in multicenter clinical trials. J Immunol Methods, 510, 113344.
Epidermal Differentiation Complex Genetic Variation in Atopic Dermatitis and Peanut Allergy
(2022). J Allergy Clin Immunol, Epub ahead of print. http://dx.doi.org/10.1016/j.jaci.2022.11.008, PMID: 36403663
Huffaker M, Kanchan K, Bahnson H, Ruczinski I, Shankar G, Leung D, Baloh, C Du Toit G, Lack GT, Nepom G, Mathias R
[PubMed]
[Citation View]
Huffaker M, Kanchan K, Bahnson H, Ruczinski I, Shankar G, Leung D, Baloh, C Du Toit G, Lack GT, Nepom G, Mathias R (2022). Epidermal Differentiation Complex Genetic Variation in Atopic Dermatitis and Peanut Allergy. J Allergy Clin Immunol, Epub ahead of print.
Epitope-Specific IgE at 1 Year of Age Can Predict Peanut Allergy Status at 5 Years
(2022). Int Arch Allergy Immunol., 184 (2), 273-278. http://dx.doi.org/10.1159/000526364, PMID: 36502801, PMCID: PMC9991938
Grinek S, Suprun M, Raghunathan R, Tomalin LE, Getts R, Bahnson T, Lack G, Sampson HA, Suarez-Farinas M.
[PubMed]
[Citation View]
Grinek S, Suprun M, Raghunathan R, Tomalin LE, Getts R, Bahnson T, Lack G, Sampson HA, Suarez-Farinas M. (2022). Epitope-Specific IgE at 1 Year of Age Can Predict Peanut Allergy Status at 5 Years. Int Arch Allergy Immunol., 184 (2), 273-278.
A CD8 + NK cell transcriptomic signature associated with clinical outcome in relapsing remitting multiple sclerosis
(2021). Nat Commun, 12 (1), 635. http://dx.doi.org/10.1038/s41467-020-20594-2, PMID: 33504809, PMCID: PMC7840761
McKinney EF, Cuthbertson I, Harris KM, Smilek D, Connor C, Manferrari G, Carr EJ, Zamvil SS, Smith KGC
[Reprint] [PubMed]
[Citation View]
McKinney EF, Cuthbertson I, Harris KM, Smilek D, Connor C, Manferrari G, Carr EJ, Zamvil SS, Smith KGC (2021). A CD8 + NK cell transcriptomic signature associated with clinical outcome in relapsing remitting multiple sclerosis. Nat Commun, 12 (1), 635.
Exhausted-like CD8 T cell phenotypes linked to C-peptide preservation in alefacept-treated T1D subjects
(2021). JCI Insight, 6 (3), 142680. http://dx.doi.org/10.1172/jci.insight.142680, PMID: 33351781, PMCID: PMC7934874
Diggins KE, Serti E, Muir VS, Rosasco M, Lu T, Balmas E, Nepom GT, Linsley PS
[Reprint] [PubMed]
[Citation View]
Diggins KE, Serti E, Muir VS, Rosasco M, Lu T, Balmas E, Nepom GT, Linsley PS (2021). Exhausted-like CD8 T cell phenotypes linked to C-peptide preservation in alefacept-treated T1D subjects. JCI Insight, 6 (3), 142680.
Differential Induction of Allergen-specific IgA Responses following Timothy Grass Subcutaneous and Sublingual Immunotherapy
(2021). J Allergy Clin Immunol, 148 (4), 1061-1071.e11. http://dx.doi.org/10.1016/j.jaci.2021.03.030, PMID: 33819508
Shamji MH, Larson D, Eifan A, Scadding GW, Qin T, Lawson K, Sever ML, Macfarlane Ellen, Layhadi JA, Wurtzen PA, Parkin RV, Sanda S, Harris KM, Nepom GT, Togias A, Durham SR
[Reprint] [PubMed]
[Citation View]
Shamji MH, Larson D, Eifan A, Scadding GW, Qin T, Lawson K, Sever ML, Macfarlane Ellen, Layhadi JA, Wurtzen PA, Parkin RV, Sanda S, Harris KM, Nepom GT, Togias A, Durham SR (2021). Differential Induction of Allergen-specific IgA Responses following Timothy Grass Subcutaneous and Sublingual Immunotherapy. J Allergy Clin Immunol, 148 (4), 1061-1071.e11.
Evolution of epitope-specific IgE and IgG 4 antibodies in children enrolled in the LEAP trial
(2021). The Journal of Allergy and Clinical Immunology, S0091-6749 (21). http://dx.doi.org/10.1016/j.jaci.2021.01.030, PMID: 33592205, PMCID: PMC8480440
Suarez-Farinas M, Suprun M, Bahnson HT, Raghunathan R, Getts R, duToit G, Lack G, Sampson HA.
[Reprint] [PubMed]
[Citation View]
Suarez-Farinas M, Suprun M, Bahnson HT, Raghunathan R, Getts R, duToit G, Lack G, Sampson HA. (2021). Evolution of epitope-specific IgE and IgG 4 antibodies in children enrolled in the LEAP trial. The Journal of Allergy and Clinical Immunology, S0091-6749 (21).
Impact of Donor and Recipient Clinical Characteristics and Hepatic Histology on Steatosis/Fibrosis Following Liver Transplantation
(2021). Transplantation, 106 (1), 106-116. http://dx.doi.org/10.1097/TP.0000000000003681, PMID: 33982909, PMCID: PMC8349377
Shaked O, Demetris J, Levitsky J, Feng S, Loza BL, Punch J, Reyes J, Klintmalm G, Jackson W, DesMarais M, Sayre P, Shaked A, Reddy KR
[Reprint] [PubMed]
[Citation View]
Shaked O, Demetris J, Levitsky J, Feng S, Loza BL, Punch J, Reyes J, Klintmalm G, Jackson W, DesMarais M, Sayre P, Shaked A, Reddy KR (2021). Impact of Donor and Recipient Clinical Characteristics and Hepatic Histology on Steatosis/Fibrosis Following Liver Transplantation. Transplantation, 106 (1), 106-116.
EAACI guideline: Preventing the development of food allergy in infants and young children
(2021). Pediatric Allergy and Immunology, 32 (5), 843-858. http://dx.doi.org/DOI: 10.1111/pai.13496, PMID: 33710678
Halken S, Muraro A, de Silva D, Khaleva E, Angier E, Arasi S, Arshad H, Bahnson HT, Beyer K, Boyle R, Du Toit G, Ebisawa M, Eigenmann P, Grimshaw K, Hoest A, Jones C, Lack G, Nadeau K, O'Mahony L, Szajewska H, Venter C, Verhasselt V, Wong GWK, Roberts G
[Reprint] [PubMed]
[Citation View]
Halken S, Muraro A, de Silva D, Khaleva E, Angier E, Arasi S, Arshad H, Bahnson HT, Beyer K, Boyle R, Du Toit G, Ebisawa M, Eigenmann P, Grimshaw K, Hoest A, Jones C, Lack G, Nadeau K, O'Mahony L, Szajewska H, Venter C, Verhasselt V, Wong GWK, Roberts G (2021). EAACI guideline: Preventing the development of food allergy in infants and young children. Pediatric Allergy and Immunology, 32 (5), 843-858.
Detection of alloreactive T cells from cryopreserved human peripheral blood mononuclear cells
(2021). J Immunol Methods, 491 (112987). http://dx.doi.org/https://doi.org/10.1016/j.jim.2021.112987, PMID: 33556344
Tanimine N, Burrell BE, Deng K, Rickert C, Lee KM, Feeney N, Pardo J, LeGuern C, Markmann JF
[PubMed]
[Citation View]
Tanimine N, Burrell BE, Deng K, Rickert C, Lee KM, Feeney N, Pardo J, LeGuern C, Markmann JF (2021). Detection of alloreactive T cells from cryopreserved human peripheral blood mononuclear cells. J Immunol Methods, 491 (112987).
Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals
(2021). Sci Transl Med., 13 (583). http://dx.doi.org/https://doi.org/10.1126/scitranslmed.abc8980, PMID: 33658358, PMCID: PMC8610022
Sims EK, Bundy BN, Stier K, Serti E, Lim N, Long SA, Geyer SM, Moran A, Greenbaum CJ, Evans-Molina C, Herold KC; Type 1 Diabetes TrialNet Study Group.
[PubMed]
[Citation View]
Sims EK, Bundy BN, Stier K, Serti E, Lim N, Long SA, Geyer SM, Moran A, Greenbaum CJ, Evans-Molina C, Herold KC; Type 1 Diabetes TrialNet Study Group. (2021). Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals. Sci Transl Med., 13 (583).
Effect of Costimulatory Blockade With Abatacept After Ustekinumab Withdrawal in Patients With Moderate to Severe Plaque Psoriasis: The PAUSE Randomized Clinical Trial
(2021). JAMA Dermatol., 157 (11), 1306-1315. http://dx.doi.org/10.1001/jamadermatol.2021.3492, PMID: 34643650, PMCID: PMC8515260
Harris KM, Smilek DE, Byron M, Lim N, Barry WT, McNamara J, Garcet S, Konrad RJ, Stengelin M, Bathala P, Korman NJ, Feldman SR, Boh EE, Barber K, Laumann AE, Helfrich YR, Krueger GG, Sofen H, Bissonnette R, Krueger JG
[Reprint] [PubMed]
[Citation View]
Harris KM, Smilek DE, Byron M, Lim N, Barry WT, McNamara J, Garcet S, Konrad RJ, Stengelin M, Bathala P, Korman NJ, Feldman SR, Boh EE, Barber K, Laumann AE, Helfrich YR, Krueger GG, Sofen H, Bissonnette R, Krueger JG (2021). Effect of Costimulatory Blockade With Abatacept After Ustekinumab Withdrawal in Patients With Moderate to Severe Plaque Psoriasis: The PAUSE Randomized Clinical Trial. JAMA Dermatol., 157 (11), 1306-1315.
Accurate and reproducible diagnosis of peanut allergy using epitope mapping
(2021). Allergy, 76 (12), 3789-3797. http://dx.doi.org/10.1111/all.14905, PMID: 33991353, PMCID: PMC8607840
Suarez-Farinas M, Suprun M, Kearney P, Getts R, Grishina G, Hayward C, Luta D, Porter A, Witmer M, Du Toit G, Lack G, Chinthrajah RS, Galli SJ, Nadeau K, Sampson H
[Reprint] [PubMed]
[Citation View]
Suarez-Farinas M, Suprun M, Kearney P, Getts R, Grishina G, Hayward C, Luta D, Porter A, Witmer M, Du Toit G, Lack G, Chinthrajah RS, Galli SJ, Nadeau K, Sampson H (2021). Accurate and reproducible diagnosis of peanut allergy using epitope mapping. Allergy, 76 (12), 3789-3797.